1 |
ชวลิต ไพโรจน์กุล |
2020 |
Opposing roles of FoxA1 and FoxA3 in intrahepatic cholangiocarcinoma progression |
International Journal of Molecular Sciences |
2 |
ชัยวัชร์ อภิวาทนสิริ |
2020 |
The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling |
Glycobiology |
3 |
ชาตรี เศรษฐเสถียร |
2020 |
Association of combined genetic variations in SOD3, GPX3, PON1, and GSTT1 with hypertension and severity of coronary artery disease |
Heart and Vessels |
4 |
ณัฐชา ภัทรผดุงกิจ |
2020 |
Comprehensive Data of P53 R282 Gene Mutation with Human Papillomaviruses (HPV)-Associated Oral Squamous Cell Carcinoma (OSCC) |
PATHOLOGY & ONCOLOGY RESEARCH |
5 |
ปิติ อึ้งอารีย์วิทยา |
2020 |
Prevalence and clinical characteristics of EBV-positive diffuse large B-cell lymphoma in adult patients: a single center study in Thailand |
Leukemia & Lymphoma |
6 |
เยาวลักษณ์ ฉ่ำกระมล |
2020 |
Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient |
Human Cell |
7 |
สักการ สังฆมานนท์ |
2020 |
In vitro and in vivo anti-tumor effects of pan-her inhibitor varlitinib on cholangiocarcinoma cell lines |
Drug Design Development and Therapy |
8 |
สุพินดา คูณมี |
2020 |
Human papillomavirus detection and abnormal anal cytology in HIV-infected patients using p16/Ki-67 dual-staining |
Asian Pacific Journal of Cancer Prevention |
9 |
กิตติ อินทุยศ |
2020 |
Reciprocal regulation between GCN2 (eIF2AK4) and PERK (eIF2AK3) through the JNK-FOXO3 axis to modulate cancer drug resistance and clonal survival |
Molecular and Cellular Endocrinology |